Adaptimmune Therapeutics Plc (ADAPY)

0.025 -0.01 (-19.09%) USD  |  OTCM  |  Jan 13, 16:00
More

Adaptimmune Therapeutics Net Common Equity Issued (Purchased) (Quarterly)

Net Common Equity Issued (Purchased) (Quarterly) Chart

View Net Common Equity Issued (Purchased) (Quarterly) for ADAPY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Common Equity Issued (Purchased) (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Common Equity Issued (Purchased) (Quarterly) Range, Past 5 Years

View Net Common Equity Issued (Purchased) (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Common Equity Issued (Purchased) (Quarterly) Benchmarks

View Net Common Equity Issued (Purchased) (Quarterly) Benchmarks
Start Trial
Biodexa Pharmaceuticals Plc --
Autolus Therapeutics Plc Upgrade
Evaxion AS Upgrade
NuCana Plc Upgrade
Mereo BioPharma Group Plc Upgrade